DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.
about
Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma.Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma.Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcomaMethods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs.The association of genetic variations in DNA repair pathways with severe toxicities in NSCLC patients undergoing platinum-based chemotherapy.Polymorphisms in translesion polymerase genes influence treatment outcome in malignant mesothelioma.
P2860
DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
DNA repair polymorphisms and t ...... inum combination chemotherapy.
@ast
DNA repair polymorphisms and t ...... inum combination chemotherapy.
@en
type
label
DNA repair polymorphisms and t ...... inum combination chemotherapy.
@ast
DNA repair polymorphisms and t ...... inum combination chemotherapy.
@en
prefLabel
DNA repair polymorphisms and t ...... inum combination chemotherapy.
@ast
DNA repair polymorphisms and t ...... inum combination chemotherapy.
@en
P2093
P1476
DNA repair polymorphisms and t ...... inum combination chemotherapy.
@en
P2093
Alenka Franko
Julija Hmeljak
Metoda Dodič-Fikfak
Nina Erčulj
Viljem Kovač
Vita Dolžan
P304
P356
10.1097/JTO.0B013E3182653D31
P577
2012-10-01T00:00:00Z